Greenberg David C. 4

What Happened

• David C. Greenberg, a director of ICU Medical (ICUI), exercised stock derivative rights and sold shares. On 2026-05-12 he exercised 2,424 shares at $101.06 per share (cost $244,969) and immediately sold those 2,424 shares in the open market at $122.91 per share for proceeds of $297,934 (net difference ≈ $52,965). The filing also shows conversion/acquisition of 1,254 shares at $0 on 2026-05-13 and a grant of 1,475 restricted stock units (RSUs) on 2026-05-13 (no exercise price).

Key Details

• Primary sale/exercise: 2026-05-12 — exercised 2,424 shares @ $101.06 (M) for $244,969; sold 2,424 shares @ $122.91 (S) for $297,934. Footnote F1 confirms sale price shown is exact.
• Additional items: 2026-05-13 — acquired 1,254 shares @ $0 (M) and disposed 1,254 shares @ $0 (M) per filing; 2026-05-13 — received grant of 1,475 RSUs @ $0 (A).
• RSU details (footnotes): these are Restricted Stock Units (F2); there is no purchase/exercise price (F3); they vest on the grant anniversary or the next annual stockholder meeting, whichever is earlier (F4).
• Shares owned after transaction: not specified in the filing.
• Timeliness: Form 4 was filed 2026-05-13 for transactions on 2026-05-12 and 2026-05-13 — filing appears timely (no late filing disclosed).

Context

• The same-day exercise and sale of 2,424 shares indicates a cashless-style exercise followed by an open-market sale (exercised then sold).
• The $0 acquisitions and disposals relate to derivative/RSU activity (no cash paid). RSU grants are compensation and vest over time; they do not necessarily signal insider market views.
• This filing documents insider transactions by a director (not a 10% owner or officer role noted here); interpret sale activity as routine insider liquidity unless additional context is provided.